Follow us on:
Breaking News
January 7, 2026
Breaking News
Breaking News
This Month at Contract Pharma
Altitude_Webinar_01-29-26_ThisMonth@

Eramol Nears Completion of New Sterile Manufacturing Facility at Sevenoaks

 
Eramol Nears Completion of New Sterile Manufacturing Facility at Sevenoaks

The site is expected to become operational in Q2 2026, subject to regulatory approval.
Read More >>

Headlines

Breaking News

Daiichi Plans to Invest $1.9B in Production Facilities

To build manufacturing facilities for cancer drugs in Japan, the U.S., Germany, and China to diversify its production capabilities.

SPONSOR

[eBook] Integrated Excellence: A Unified Approach To Development, Manufacturing, Testing, And Storage

As drug development grows increasingly complex, pharma and biotech teams are seeking partners with the scientific depth and agility to keep pace.

Breaking News
Collaborations & Alliances

Ascidian Therapeutics, Forge Biologics Partner to Advance Stargardt Treatment

Forge to provide Ascidian with process and analytical development services, toxicology, and cGMP manufacturing.

Breaking News

Sharp Sterile Manufacturing to Invest $28M in Lee, MA Site

The expansion will more than double the facility’s filling capacity.

SPONSOR

Next-Generation Topical Approach: A Breakthrough in Liposome-Integrated Formulations

Topical delivery is evolving. Discover how liposome-integrated formulations enhance penetration, retention & therapeutic effect.

IQVIA_eBook_0925_650x250

Breaking News

Novo Nordisk’s International Operations Adopt Veeva Vault CRM

Veeva to deliver next-gen customer engagement with agentic AI for Novo Nordisk.

SPONSOR

The Evolution of Biotech and CDMO Partnerships: A 2026 Outlook

If there’s one constant in drug development today, it’s that the pressure of speed to clinic is only ever increasing.

Featured Resources

Free Basic Listing SPOTLIGHT

gChem

gChem supplies high-purity DMSO for pharmaceutical innovation—supporting drug discovery, API synthesis, and analytical development. Engineered for safety and performance, our DMSO serves as a versatile excipient or API, playing a vital role in advancing modern medicine.

 

Solution Content Centers SPOTLIGHT

Sentry BioPharma Services ApS

Sentry BioPharma Services ApS (Sentry EU) is a contract service organization (CSO) which supports the life science industry throughout the drug development life cycle by offering cGMP temperature-controlled storage, distribution, logistics, and EMA compliant labeling and packaging services. Sentry EU's Qualified Person (QP) facilitates import/export of pharmaceuticals to/from the EU via QP audits, QP-to-QP agreements, and batch certification/declarations. Sentry EU’s validated software, cGMP storage and drug distribution facility, industry expertise, and stringent quality standards support pharmaceutical supply chain integrity throughout manufacturing, packaging, storage and distribution.